Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Sugammadex

April 17, 2023 CD as API / Uncategorized

Neostigmine vs. sugammadex: on postoperative nausea and vomiting (PONV) after general anaesthesia

Sugammadex (SGM) is the first cyclodextrin derivative approved as an API, the result of a rational drug design, with a

Continue reading

September 28, 2022 Analysis / CD derivatives / Non-pharma applications

Sugammadex, Subetadex and Sualphadex as chiral selectors

The present contribution describes for the first time the application of three single-isomeric cyclodextrin derivatives – Sugammadex, Subetadex and Sualphadex

Continue reading

September 7, 2022 CD as API / Pharma applications

Appropriate Dosing of Sugammadex in Morbidly Obese Patients

A meta-analysis has been recently published about the dosing of sugammadex (SGM) for neuromuscular blockade (NMB) induced muscle relaxation in

Continue reading

June 15, 2022 CD as API / Pharma applications / Uncategorized

Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis

Background: A recent survey revealed that extensive off-label use of sugammadex in pediatric anesthesia deserved particular attention. The present study

Continue reading

February 2, 2022 CD as API / Pharma applications

Sugammadex in Colorectal and da Vinci Surgery

Traditionally, reversal of neuromuscular blocking agents following the completion of surgery was achieved with cholinesterase inhibitors. Recently, sugammadex has been

Continue reading

December 2, 2021 Uncategorized

Molecular interactions in remdesivir-cyclodextrin systems

In a recently published study intermolecular interactions of remdesivir and various cyclodextrin derivatives were characterized by extensive NMR spectroscopy. The

Continue reading

September 28, 2021 CD as API / Pharma applications

Comparison of Selective Relaxant Binding Agent Adamgammadex Sodium with Sugammadex for Reversing Rocuronium-Induced Deep Neuromuscular Block

Zhao et al. reported on a phase IIa, single-center, randomized, open-label, and dose-finding study that enrolled 35 patients under general

Continue reading

September 20, 2021 CD as API / Pharma applications

Sugammadex, the Guardian of Deep Muscle Relaxation During Conventional and Robot-Assisted Laparoscopic Surgery: A Narrative Review.

High intra-abdominal pressure induced by artificial pneumoperitoneum can obviously impair respiratory and circulatory functions and has a negative effect on

Continue reading

August 24, 2021 CD as API / Pharma applications

Carboxymethyl-γ-cyclodextrin, a novel selective relaxant binding agent for the reversal of neuromuscular block induced by aminosteroid neuromuscular blockers: an ex vivo laboratory study

Residual neuromuscular block at the end of surgery may compromise the patient’s safety. The risk of airway complications can be

Continue reading

July 29, 2021 CD as API / CD derivatives / Pharma applications

Possible immunoglobulin-E-dependent sugammadex-induced anaphylaxis caused by an epitope other than γ-cyclodextrin: a case report

A 55-year-old Japanese man underwent a laryngectomy under general anesthesia. One month before laryngectomy, he had undergone laryngoscopy under general

Continue reading

Posts pagination

«Previous Posts 1 2 3 Next Posts»

Recent Posts

  • Comparative Study of Nanosuspensions for Acetogenins Delivery
  • Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches
  • Events of American Cyclodextrin Consortium
  • Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
  • Nano-Enabled Toxicity of Pharmaceutical Excipients

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (66)
  • CD as API (347)
  • CD derivatives (410)
  • Cosmetics and toilettry (51)
  • Diagnosis (12)
  • Drug delivery (791)
  • E-ducation (63)
  • Environmental (134)
  • Events (234)
  • Food (222)
  • Gene delivery (20)
  • Household products (1)
  • Household products (4)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (400)
  • Other industrial use (106)
  • Pharma applications (1,183)
  • Supramolecular systems (40)
  • Uncategorized (146)

Top Posts

  • Comparative Study of Nanosuspensions for Acetogenins Delivery
  • Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Harnessing Organoid Platforms for Nanoparticle Drug Development
  • Sustained transdermal delivery of insulin-cyclodextrin through the use of chitosan-based microneedle patches
  • A sugammadex-analogue, per-6-O-carboxyhexyl-thio-gamma-CD (OKL-1111) is a highly potent and universal reversal agent for anticoagulants
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
  • Postponed to August 5-7: 10th Annual Congress of Nano Science and Technology-2020 (Nano S&T-2020)
  • Synthesis of cyclodextrin‐based radial polycatenane cyclized by amide bond and subsequent fabrication of water‐soluble derivatives
  • Algae motors embedded in a degradable capsule for drug delivery

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,473 other subscribers

Loading Comments...